The United States Food and Drug Administration (FDA) has issued an alert regarding certain medications, specifically Valsartan and Valsartan/HCTZ, which are commonly prescribed for controlling blood pressure.
An impurity known as NMDA has been detected in some of these products, which may potentially pose a cancer risk. As a result, the FDA has recommended a recall of the affected drugs.
If you are currently taking this medication, please don’t be alarmed. We have a system in place to address this matter swiftly. Contact us as soon as possible, and we will assist you in switching to an alternative medication.
Our nephrology team meets with you to understand your medical history, current kidney condition, and health goals.
We prepare an individualized kidney care plan based on your specific diagnosis and treatment needs.
We coordinate the necessary resources—medications, equipment, and support services to ensure effective renal care delivery.
.svg)
